DexCom Inc (DXCM)
127.23
-10.78
(-7.81%)
USD |
NASDAQ |
Apr 26, 12:27
DexCom Cash from Investing (TTM): -507.20M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -507.20M |
September 30, 2023 | -1.116B |
June 30, 2023 | -707.40M |
March 31, 2023 | -296.40M |
December 31, 2022 | -521.50M |
September 30, 2022 | -823.50M |
June 30, 2022 | -1.024B |
March 31, 2022 | -515.70M |
December 31, 2021 | -216.10M |
September 30, 2021 | 256.00M |
June 30, 2021 | 217.70M |
March 31, 2021 | -1.261B |
December 31, 2020 | -1.018B |
September 30, 2020 | -1.088B |
June 30, 2020 | -1.492B |
March 31, 2020 | -1.016B |
December 31, 2019 | -1.015B |
September 30, 2019 | -890.00M |
June 30, 2019 | -472.60M |
March 31, 2019 | 6.90M |
December 31, 2018 | -139.80M |
September 30, 2018 | -171.80M |
June 30, 2018 | -213.00M |
March 31, 2018 | -138.40M |
December 31, 2017 | -144.40M |
Date | Value |
---|---|
September 30, 2017 | -160.60M |
June 30, 2017 | -141.80M |
March 31, 2017 | -66.10M |
December 31, 2016 | -55.90M |
September 30, 2016 | -51.30M |
June 30, 2016 | -39.20M |
March 31, 2016 | -36.80M |
December 31, 2015 | -51.50M |
September 30, 2015 | -43.50M |
June 30, 2015 | -41.60M |
March 31, 2015 | -38.40M |
December 31, 2014 | -16.80M |
September 30, 2014 | -11.60M |
June 30, 2014 | -6.10M |
March 31, 2014 | 4.00M |
December 31, 2013 | 20.90M |
September 30, 2013 | 27.00M |
June 30, 2013 | 28.80M |
March 31, 2013 | 29.30M |
December 31, 2012 | 28.40M |
September 30, 2012 | 18.32M |
June 30, 2012 | 4.223M |
March 31, 2012 | -41.48M |
December 31, 2011 | -46.40M |
September 30, 2011 | -63.34M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.492B
Minimum
Jun 2020
256.00M
Maximum
Sep 2021
-710.88M
Average
-823.50M
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
Abbott Laboratories | -3.133B |
Edwards Lifesciences Corp | 173.80M |
Intuitive Surgical Inc | -1.062B |
Cardinal Health Inc | -465.00M |
Insulet Corp | -119.40M |